PMP22 inhibitors are a class of chemical compounds that specifically target Peripheral Myelin Protein 22 (PMP22), a transmembrane glycoprotein predominantly expressed in Schwann cells of the peripheral nervous system. PMP22 plays a critical role in the formation and maintenance of myelin sheaths around peripheral nerves, which are essential for rapid nerve impulse conduction. By inhibiting PMP22, these compounds modulate the protein's function or expression, leading to alterations in myelin sheath formation and peripheral nerve physiology. The study of PMP22 inhibitors provides valuable insights into the molecular mechanisms underlying myelination processes, protein trafficking, and cellular homeostasis within the peripheral nervous system. Additionally, these inhibitors serve as important tools for understanding the pathophysiology of conditions associated with abnormal PMP22 expression, such as demyelination and nerve degeneration.
PMP22 inhibitors encompass a diverse range of structures, often designed to interact with specific domains of the PMP22 protein or to interfere with its gene expression. Some inhibitors bind directly to the protein, altering its conformation, stability, or localization within the cell membrane, while others affect the transcriptional or translational regulation of the PMP22 gene. These compounds can include small molecules, peptides, or nucleic acid-based agents like antisense oligonucleotides and siRNA. Researchers utilize PMP22 inhibitors in experimental models to dissect pathways involved in myelin formation, protein folding, and degradation, as well as to explore the consequences of altered PMP22 levels on cellular function. By employing these inhibitors, scientists investigate the complex interplay between Schwann cells and neurons, elucidate factors that influence peripheral nerve integrity, and advance the understanding of protein regulation in neural tissues. This knowledge contributes to the broader field of neurobiology and aids in identifying key molecular targets involved in nerve development and maintenance.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Influences gene expression and cell differentiation, potentially affecting PMP22 expression in Schwann cells. | ||||||
Prednisone | 53-03-2 | sc-205816 sc-205816A sc-205816B | 1 g 5 g 25 g | $42.00 $136.00 $676.00 | 2 | |
Can modulate gene expression and inflammatory responses, possibly impacting PMP22 expression. | ||||||
L-Ascorbic acid, free acid | 50-81-7 | sc-202686 | 100 g | $46.00 | 5 | |
Shown to promote myelin formation; may have an indirect effect on PMP22 expression or function. | ||||||
L-Thyroxine, free acid | 51-48-9 | sc-207813 sc-207813A | 100 mg 500 mg | $35.00 $74.00 | 2 | |
Influence neural development and myelination, potentially affecting PMP22 expression. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Influences signaling pathways involved in cell differentiation and survival, possibly impacting PMP22. | ||||||
Fingolimod | 162359-55-9 | sc-507334 | 10 mg | $160.00 | ||
A sphingosine-1-phosphate receptor modulator, could indirectly affect myelination processes involving PMP22. | ||||||
Fluoxetine | 54910-89-3 | sc-279166 | 500 mg | $318.00 | 9 | |
An SSRI, has been shown to affect neural plasticity, potentially influencing PMP22-related pathways. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Influences cellular differentiation and immune modulation, potentially affecting PMP22. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Modulate cellular growth and survival pathways, potentially impacting PMP22 expression. | ||||||
5,5-Diphenyl Hydantoin | 57-41-0 | sc-210385 | 5 g | $70.00 | ||
Used in neural conditions; its effects on nerve cells might indirectly influence PMP22. | ||||||